Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-11-05

Clinical Trial Update: Mechanism of Masked Hypertension - Intervention [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating mechanism of masked hypertension was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Masked Hypertension | Phase 3 | Status: WITHDRAWN